BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27281358)

  • 1. High metabolic characteristics of uterine fibroids in 18F-FDG PET/CT imaging and the underlying mechanisms.
    Ma Y; Shao X; Shao X; Wang X; Wang Y
    Nucl Med Commun; 2016 Nov; 37(11):1206-11. PubMed ID: 27281358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-dependent variations in 18F-fluorodeoxyglucose uptake in uterine leiomyomas.
    Lerman H; Bar-On S; Helpman L; Even-Sapir E; Grisaru D
    Int J Gynecol Cancer; 2012 Sep; 22(7):1187-91. PubMed ID: 22801027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FES and 18F-FDG PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: correlation with immunohistochemical analysis.
    Zhao Z; Yoshida Y; Kurokawa T; Kiyono Y; Mori T; Okazawa H
    J Nucl Med; 2013 Apr; 54(4):499-506. PubMed ID: 23471314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant Hypermetabolism of Benign Uterine Leiomyoma on 18F-FDG PET/CT.
    Nunes RF; Queiroz MA; Buchpiguel CA; Carvalho FM; Carvalho JP
    Clin Nucl Med; 2019 Jun; 44(6):e413-e414. PubMed ID: 30985441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FLT PET performs better than 18F-FDG PET in differentiating malignant uterine corpus tumors from benign leiomyoma.
    Yamane T; Takaoka A; Kita M; Imai Y; Senda M
    Ann Nucl Med; 2012 Jul; 26(6):478-84. PubMed ID: 22477262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F-18 fluorodeoxyglucose uptake in leiomyomatous uterus.
    Shida M; Murakami M; Tsukada H; Ishiguro Y; Kikuchi K; Yamashita E; Kajiwara H; Yasuda M; Ide M
    Int J Gynecol Cancer; 2007; 17(1):285-90. PubMed ID: 17291269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and characteristics of uterine leiomyomas with FDG uptake.
    Nishizawa S; Inubushi M; Kido A; Miyagawa M; Inoue T; Shinohara K; Kajihara M
    Ann Nucl Med; 2008 Nov; 22(9):803-10. PubMed ID: 19039559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F-18 FDG PET in detecting uterine leiomyoma.
    Lin CY; Ding HJ; Chen YK; Liu CS; Lin CC; Kao CH
    Clin Imaging; 2008; 32(1):38-41. PubMed ID: 18164393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between sex hormones levels and 18F-FDG uptake by the ovaries in premenopausal woman.
    Kim TH; Kim MR; Jung Y; An YS
    Radiol Oncol; 2019 Sep; 53(3):293-299. PubMed ID: 31553705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.
    Park JY; Lee JW; Lee HJ; Lee JJ; Moon SH; Kang SY; Cheon GJ; Chung HH
    J Gynecol Oncol; 2017 May; 28(3):e28. PubMed ID: 28382795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-fluorodeoxyglucose uptake in uterine leiomyomas in healthy women.
    Tsukada H; Murakami M; Shida M; Kikuchi K; Watanabe M; Yasuda S; Suzuki Y
    Clin Imaging; 2009; 33(6):462-7. PubMed ID: 19857807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of 2-[18F]fluoro-2-deoxy-D-glucose in uterine leiomyoma: imaging of four patients by coincidence positron emission tomography.
    Ak I; Ozalp S; Yalçin OT; Zor E; Vardareli E
    Nucl Med Commun; 2004 Sep; 25(9):941-5. PubMed ID: 15319600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI.
    Kitajima K; Murakami K; Yamasaki E; Kaji Y; Sugimura K
    Ann Nucl Med; 2008 Jul; 22(6):505-12. PubMed ID: 18670857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of PET/CT to exclude leiomyoma in patients with lesions suspicious for uterine sarcoma on MRI.
    Kusunoki S; Terao Y; Ujihira T; Fujino K; Kaneda H; Kimura M; Ota T; Takeda S
    Taiwan J Obstet Gynecol; 2017 Aug; 56(4):508-513. PubMed ID: 28805609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG uptake in brown adipose tissue-a brief report on brown fat with FDG uptake mechanisms and quantitative analysis using dual-time-point FDG PET/CT.
    Esen Akkas B; Gökaslan D; Güner L; Ilgin Karabacak N
    Rev Esp Med Nucl; 2011; 30(1):14-8. PubMed ID: 20702004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study.
    Cokmert S; Tanriverdi O; Karapolat I; Demir L; Bayoglu V; Can A; Akyol M; Yilmaz Y; Oktay Tarhan M
    J BUON; 2016; 21(6):1410-1418. PubMed ID: 28039701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of primary tumor (18)F-FDG uptake on preoperative PET/CT for predicting intratumoral lymphatic invasion and axillary nodal metastasis.
    Jung NY; Kim SH; Kang BJ; Park SY; Chung MH
    Breast Cancer; 2016 Sep; 23(5):712-7. PubMed ID: 26219608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multiparametric MRI-based machine learning to distinguish between uterine sarcoma and benign leiomyoma: comparison with
    Nakagawa M; Nakaura T; Namimoto T; Iyama Y; Kidoh M; Hirata K; Nagayama Y; Oda S; Sakamoto F; Shiraishi S; Yamashita Y
    Clin Radiol; 2019 Feb; 74(2):167.e1-167.e7. PubMed ID: 30471748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do 18F-FDG PET/CT findings have a relationship with histopathological and immunohistochemical factors of breast cancer in men?
    Vatankulu B; Işik G; Kocael P; Kuyumcu S; Ilvan Ş; Sağer S; Halaç M; Türkmen C; Sönmezoğlu K
    Nucl Med Commun; 2016 Dec; 37(12):1273-1281. PubMed ID: 27472037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Importance of Bone Marrow Uptake on Baseline
    Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
    Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.